首页> 美国卫生研究院文献>Nucleic Acids Research >Fusoselect: cell–cell fusion activity engineered by directed evolution of a retroviral glycoprotein
【2h】

Fusoselect: cell–cell fusion activity engineered by directed evolution of a retroviral glycoprotein

机译:Fusoselect:通过逆转录病毒糖蛋白的定向进化设计的细胞间融合活性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Membrane fusion plays a key role in many biological processes including vesicle trafficking, synaptic transmission, fertilization or cell entry of enveloped viruses. As a common feature the fusion process is mediated by distinct membrane proteins. We describe here ‘Fusoselect’, a universal procedure allowing the identification and engineering of molecular determinants for cell–cell fusion-activity by directed evolution. The system couples cell–cell fusion with the release of retroviral particles, but can principally be applied to membrane proteins of non-viral origin as well. As a model system, we chose a γ-retroviral envelope protein, which naturally becomes fusion-active through proteolytic processing by the viral protease. The selection process evolved variants that, in contrast to the parental protein, mediated cell–cell fusion in absence of the viral protease. Detailed analysis of the variants revealed molecular determinants for fusion competence in the cytoplasmic tail (CT) of retroviral Env proteins and demonstrated the power of Fusoselect.
机译:膜融合在许多生物学过程中起关键作用,包括囊泡运输,突触传递,受精或包膜病毒进入细胞。作为共同特征,融合过程由不同的膜蛋白介导。我们在这里描述“ Fusoselect”,这是一种通用程序,可以通过定向进化来鉴定和工程化决定细胞-细胞融合活性的分子决定子。该系统将细胞间融合与逆转录病毒颗粒的释放结合在一起,但原则上也可以应用于非病毒来源的膜蛋白。作为模型系统,我们选择了γ-逆转录病毒包膜蛋白,该蛋白通过病毒蛋白酶的蛋白水解过程自然具有融合活性。与亲本蛋白相比,选择过程中产生了变异体,这种变异体是在没有病毒蛋白酶的情况下介导的细胞间融合。对变体的详细分析揭示了逆转录病毒Env蛋白在细胞质尾部(CT)中融合能力的分子决定因素,并证明了Fusoselect的功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号